trending Market Intelligence /marketintelligence/en/news-insights/trending/IR4ukyfhYbL78MUM321Asg2 content esgSubNav
In This List

Galmed Pharmaceuticals to raise $2.7M through direct offering, private placement

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Blog

Insight Weekly: PE firms shift strategies; bank earnings kick off; bankruptcies plummet

Blog

Insight Weekly: Stocks limp into 2023; GCC banks set for rebound; deep-sea mining faces pushback

Blog

Infographic: The Big Picture 2023 Issuer & Investor Relations Outlook


Galmed Pharmaceuticals to raise $2.7M through direct offering, private placement

Galmed Pharmaceuticals Ltd. said it will sell 332,038 ordinary shares at $7.10 apiece in a registered direct offering.

The company said it will also offer its chairman and a board member a total of 49,295 restricted ordinary shares at $7.10 apiece in a concurrent private placement.

Total gross proceeds from the offerings are expected to be about $2.7 million.

The direct offering is expected to close around Aug. 9, while the private placement is expected to close by Sep. 15. Both are subject to customary closing conditions.